Parasitology Research

, Volume 103, Issue 1, pp 1–10

Leishmaniasis treatment—a challenge that remains: a review

  • Dilvani O. Santos
  • Carlos E. R. Coutinho
  • Maria F. Madeira
  • Carolina G. Bottino
  • Rodrigo T. Vieira
  • Samara B. Nascimento
  • Alice Bernardino
  • Saulo C. Bourguignon
  • Suzana Corte-Real
  • Rosa T. Pinho
  • Carlos Rangel Rodrigues
  • Helena C. Castro
Review

DOI: 10.1007/s00436-008-0943-2

Cite this article as:
Santos, D.O., Coutinho, C.E.R., Madeira, M.F. et al. Parasitol Res (2008) 103: 1. doi:10.1007/s00436-008-0943-2

Abstract

Leishmaniasis is a disease caused by flagellate protozoan Leishmania spp. and represents an emergent illness with high morbidity and mortality in the tropics and subtropics. Since the discovery of the first drugs for Leishmaniasis treatment (i.e., pentavalent antimonials), until the current days, the search for substances with antileishmanial activity, without toxic effects, and able to overcome the emergence of drug resistant strains still remains as the current goal. This article reports the development of new chemotherapies through the rational design of new drugs, the use of products derived from microorganisms and plants, and treatments related to immunity as new alternatives for the chemotherapy of leishmaniasis.

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Dilvani O. Santos
    • 1
  • Carlos E. R. Coutinho
    • 1
  • Maria F. Madeira
    • 2
  • Carolina G. Bottino
    • 1
  • Rodrigo T. Vieira
    • 1
  • Samara B. Nascimento
    • 1
  • Alice Bernardino
    • 3
  • Saulo C. Bourguignon
    • 1
  • Suzana Corte-Real
    • 4
  • Rosa T. Pinho
    • 4
  • Carlos Rangel Rodrigues
    • 5
  • Helena C. Castro
    • 1
  1. 1.Laboratório de Biopatógenos e Ativação Celular (LaBiopAc), Departamento de Biologia Celular e Molecular, Instituto de BiologiaUniversidade Federal Fluminense (UFF)NiteróiBrazil
  2. 2.Instituto de Pesquisa Clínica Evandro Chagas (IPEC)Fundação Oswaldo Cruz- FIOCRUZManguinhosBrazil
  3. 3.Instituto de Química, UFFNiteróiBrazil
  4. 4.Laboratório de Imunologia ClínicaInstituto Oswaldo CruzManguinhosBrazil
  5. 5.Laboratório de Modelagem Molecular e QSAR (ModMolQSAR), Faculdade de FarmáciaUniversidade Federal do Rio de JaneiroRio de JaneiroBrazil